All In Biotech

Drug Trial Radar · NCT00779714

Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC

Prospectively Randomized Phase III Study of an Individualized Sensitivity-Directed Combination Chemotherapy Versus DTIC as First-Line Treatment in Stage IV Metastatic Melanoma

Last checked: Nov 20, 2026Latest source record: Oct 24, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

360

Planned (sponsor's estimate)

Start

Oct 2008

Primary completion

Oct 2012

Study completion Apr 2013

Sponsor

Lead sponsor
University of WuerzburgAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Hiege-Stiftung gegen Hautkrebs; medac GmbH; DCS Innovative Diagnostik Systeme
First posted
Oct 24, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial is aimed to investigate the efficacy of an individualized, sensitivity-directed combination chemotherapy in comparison to the standard regimen DTIC. Two question are aimed to be answered by this study: 1. Is the individual chemosensitivity index (BICSI) a prognostic / predictive biomarker for chemotherapy ? 2. Is an individualized, sensitivity-directed combination chemotherapy superior to the standard regimen DTIC in terms of survival and response ?

Conditions

  • Melanoma

Interventions

  • DTIC (dacarbazine)Drug

    1000 mg/m2, d1 every 21 days

  • paclitaxel + cisplatinDrug

    paclitaxel 200 mg/m2 cisplatin 50 mg/m2 d1 every 21 days

  • treosulfan + cytarabineDrug

    treosulfan 2500 mg/m2, d2 cytarabine 100 mg/m2, d1-3 every 21 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease-specific overall survivalTime frame: 4 years

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • Dept of Dermatology, University of Aachen

    Aachen, Germany · Recruiting

  • Dept of Dermatology, University of Berlin Charite

    Berlin, Germany · Recruiting

  • Dept of Dermatology, University of Bochum

    Bochum, Germany · Recruiting

  • Medizinisches Zentrum Bonn Friedensplatz

    Bonn, Germany · Recruiting

  • Dept of Dermatology, University of Essen

    Essen, Germany · Recruiting

  • Dermatology, Klinikum Frankfurt/Oder

    Frankfurt (Oder), Germany · Recruiting

  • Dept of Dermatology, University of Frankfurt

    Frankfurt am Main, Germany · Recruiting

  • Dept of Dermatology, University of Hannover

    Hanover, Germany · Recruiting

  • Dept of Dermatology, Saarland University

    Homburg/Saar, Germany · Recruiting

  • Dept of Dermatology, University of Jena

    Jena, Germany · Recruiting

  • Dept of Dermatology, University of Schleswig-Holstein Campus Kiel

    Kiel, Germany · Recruiting

  • Dept of Dermatology, University of Schleswig-Holstein Campus Luebeck

    Lübeck, Germany · Recruiting

  • Dermatology, Klinikum Ludwishafen

    Ludwigshafen, Germany · Recruiting

  • Dept of Dermatology, Univeristy of Magdeburg

    Magdeburg, Germany · Recruiting

  • Dept of Dermatology, University of Mainz

    Mainz, Germany · Recruiting

  • Dept of Dermatology, University of Mannheim

    Mannheim, Germany · Recruiting

  • Dept of Dermatology, University of Marburg

    Marburg, Germany · Recruiting

  • Dept of Dermatology, University of Muenchen

    München, Germany · Recruiting

  • Dept of Dermatology, University of Muenster

    Münster, Germany · Recruiting

  • Dept of Medical Oncology, Fachklinik Hornheide

    Münster, Germany · Recruiting

  • Dermatology, Klinikum Dorothea Christiane Erxleben

    Quedlinburg, Germany · Recruiting

  • Dept of Dermatology, University of Tuebingen

    Tübingen, Germany · Recruiting

  • Dept of Dermatology, University of Wuerzburg

    Würzburg, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.